Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6237710rdf:typepubmed:Citationlld:pubmed
pubmed-article:6237710lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6237710lifeskim:mentionsumls-concept:C0678222lld:lifeskim
pubmed-article:6237710lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:6237710lifeskim:mentionsumls-concept:C0475264lld:lifeskim
pubmed-article:6237710pubmed:issue10lld:pubmed
pubmed-article:6237710pubmed:dateCreated1984-11-28lld:pubmed
pubmed-article:6237710pubmed:abstractTextImmune-deprived mice bearing HX99 human breast carcinoma xenografts were injected with a radiolabelled monoclonal antibody, LICR-LON-M8 (M8), to investigate the dependence of tumour localization on (i) tumour site and (ii) antibody radiolabel. No significant difference was found in the degree of localization of radio-iodinated M8 in subcutaneous, renal or intracranial xenografts, but a highly significant improvement in HX99 localization by M8 was recorded using an 111indium-DTPA conjugate of the antibody (111In-DTPA-M8), related to its rapid tumour uptake and blood pool clearance. Radio-iodinated or 111In-labelled M8 was given to 29 patients with breast cancer, 7 with primary tumours and 22 with metastases. Tumour localization was assessed by (i) examination of surgical specimens and (ii) antibody scans, which were compared with conventional X-rays and 99mTc-methylene diphosphonate (MDP) bone scans. Radiolabelled M8 localized preferentially in all primary tumours (radioactivity tumour: normal breast = 6.2 +/- 1.4 [mean +/- s.e.]). All ten patients with skeletal metastases had positive 111In-DTPA-M8 scans, but the correlation with X-rays and MDP scans showed a regional variation. Radio-iodinated M8 failed to identify metastases in any site. The favourable biodistribution of 111In-DTPA-M8 has led to the clear localization of breast carcinomas in patients and mice. In future such reagents may rationalize the clinical management of breast cancer.lld:pubmed
pubmed-article:6237710pubmed:languageenglld:pubmed
pubmed-article:6237710pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6237710pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6237710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6237710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6237710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6237710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6237710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6237710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6237710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6237710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6237710pubmed:statusMEDLINElld:pubmed
pubmed-article:6237710pubmed:monthOctlld:pubmed
pubmed-article:6237710pubmed:issn0007-1323lld:pubmed
pubmed-article:6237710pubmed:authorpubmed-author:RainsburyR...lld:pubmed
pubmed-article:6237710pubmed:issnTypePrintlld:pubmed
pubmed-article:6237710pubmed:volume71lld:pubmed
pubmed-article:6237710pubmed:ownerNLMlld:pubmed
pubmed-article:6237710pubmed:authorsCompleteYlld:pubmed
pubmed-article:6237710pubmed:pagination805-12lld:pubmed
pubmed-article:6237710pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:meshHeadingpubmed-meshheading:6237710-...lld:pubmed
pubmed-article:6237710pubmed:year1984lld:pubmed
pubmed-article:6237710pubmed:articleTitleThe localization of human breast carcinomas by radiolabelled monoclonal antibodies.lld:pubmed
pubmed-article:6237710pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6237710pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6237710pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6237710lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6237710lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6237710lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6237710lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6237710lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6237710lld:pubmed